Nexium Iv

   
Google
 
Web NewDrugInformation.com

Nexium Iv


Drug - Nexium Iv
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INTRAVENOUS
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Esomeprazole Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 20MG BASE/VIAL
The potency of the active ingredient(s), Esomeprazole Sodium. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Nexium Iv. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021689
The FDA assigned number to Nexium Iv. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nexium Iv. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 31, 2005
The date Nexium Iv was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Nexium Iv. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Nexium Iv is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Lp
The full name of the firm holding legal responsibility for the new application of Nexium Iv.

Nexium Iv